异恶唑
流出
化学
甲酰胺
结核分枝杆菌
立体化学
酮内酯
肺结核
药理学
微生物学
抗生素
抗菌剂
生物
生物化学
医学
病理
作者
Elisa Azzali,Diana Machado,Amit Kaushik,Federica Vacondio,Sara Flisi,Clotilde Silvia Cabassi,Gyanu Lamichhane,Miguel Viveiros,Gabriele Costantino,Marco Pieroni
标识
DOI:10.1021/acs.jmedchem.7b00793
摘要
Tuberculosis remains one of the deadliest infectious diseases in the world, and the increased number of multidrug-resistant and extremely drug-resistant strains is a significant reason for concern. This makes the discovery of novel antitubercular agents a cogent priority. We have previously addressed this need by reporting a series of substituted 2-aminothiazoles capable to inhibit the growth of actively replicating, nonreplicating persistent, and resistant Mycobacterium tuberculosis strains. Clues from the structure–activity relationships lining up the antitubercular activity were exploited for the rational design of improved analogues. Two compounds, namely N -phenyl-5-(2-( p -tolylamino)thiazol-4-yl)isoxazole-3-carboxamide 7a and N -(pyridin-2-yl)-5-(2-( p -tolylamino)thiazol-4-yl)isoxazole-3-carboxamide 8a, were found to show high inhibitory activity toward susceptible M. tuberculosis strains, with an MIC 90 of 0.125–0.25 μg/mL (0.33–0.66 μM) and 0.06–0.125 μg/mL (0.16–0.32 μM), respectively. Moreover, they maintained good activity also toward resistant strains, and they were selective over other bacterial species and eukaryotic cells, metabolically stable, and apparently not susceptible to the action of efflux pumps.
科研通智能强力驱动
Strongly Powered by AbleSci AI